Interferon-Alpha Clinical Trials

1 actively recruiting trial

Also known as: Interferon, alpha interferon, Intron® A, Roferon® A

Pipeline

Phase 3: 1

Top Sponsors

University of Birmingham1

Indications

Polycythemia Vera1
Cancer1

Other1 trial

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.